Cancer chemoprevention with PV-1, a novel Prunella vulgaris -containing herbal mixture that remodels the tumor immune microenvironment in mice

The herb has shown significant immune-stimulatory and anti-inflammatory effects in mouse models. Here, the effects of a novel -containing herbal mixture, PV-1, were examined in several mouse models for cancer, including chemically induced models of lung and oral cancers as well as syngraft models fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2023, Vol.14, p.1196434-1196434
Hauptverfasser: Zhang, Qi, Chen, Xu, Palen, Katie, Johnson, Bryon, Bui, Dinh, Xiong, Donghai, Pan, Jing, Hu, Ming, Wang, Yian, You, Ming
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The herb has shown significant immune-stimulatory and anti-inflammatory effects in mouse models. Here, the effects of a novel -containing herbal mixture, PV-1, were examined in several mouse models for cancer, including chemically induced models of lung and oral cancers as well as syngraft models for lung cancer and melanoma. PV-1, consisting of extracts from , , and , exhibited no toxicity in a dose escalation study in A/J mice. PV-1 significantly inhibited mouse lung tumor development induced by the lung carcinogens vinyl carbamate and benzo[a]pyrene. PV-1 also hindered the induction of oral squamous cell carcinomas in C57BL/6 mice caused by 4-nitroquinoline-1-oxide. Flow cytometry analysis showed that PV-1 increased the numbers of CD8+ tumor-infiltrating lymphocytes (TILs) and increased the production of granzyme B, TNF-α, and IFN-γ by CD8+ TILs. PV-1 also suppressed granulocytic myeloid-derived suppressor cell numbers (g-MDSCs) and improved the anti-cancer activity of anti-PD-1 immunotherapy. These results indicate that PV-1 remodels the tumor immune microenvironment by selectively inhibiting g-MDSCs and increasing CD8+ TILs within tumors, resulting in decreased immune suppression and enhanced cancer chemopreventive efficacy.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1196434